Cargando…

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies

BACKGROUND: Juvenile dermatomyositis (JDM) is a systemic autoimmune disease with a prominent interferon (IFN) signature, but the pathogenesis of JDM and the etiology of its IFN signature remain unknown. The Mendelian autoinflammatory interferonopathies, Chronic Atypical Neutrophilic Dermatosis with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hanna, Gunter-Rahman, Fatima, McGrath, John A., Lee, Esther, de Jesus, Adriana A., Targoff, Ira N., Huang, Yan, O’Hanlon, Terrance P., Tsai, Wanxia L., Gadina, Massimo, Miller, Frederick W., Goldbach-Mansky, Raphaela, Rider, Lisa G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137415/ https://www.ncbi.nlm.nih.gov/pubmed/32252809 http://dx.doi.org/10.1186/s13075-020-02160-9

Ejemplares similares

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Editorial: Insights in autoimmune and autoinflammatory disorders: 2021
por: Goldbach-Mansky, Raphaela, et al.
Publicado: (2022)

Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18
por: Alehashemi, Sara, et al.
Publicado: (2020)

Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases
por: Alehashemi, Sara, et al.
Publicado: (2022)

Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)
por: Kanazawa, Nobuo, et al.
Publicado: (2023)

Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
por: Gagne, Samuel, et al.
Publicado: (2023)

Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report
por: Schnappauf, Oskar, et al.
Publicado: (2021)

Development of the autoinflammatory disease damage index (ADDI)
por: Annink, K, et al.
Publicado: (2015)

Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis
por: Frémond, M-L, et al.
Publicado: (2015)

Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies
por: Rider, Lisa G., et al.
Publicado: (2010)

Proceedings from the 2(nd) Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
por: Canna, Scott W., et al.
Publicado: (2020)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)

Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
por: Lanis, Aviya, et al.
Publicado: (2022)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Serum IL-18 is a specific biomarker for Macrophage Activation Syndrome across several autoinflammatory diseases
por: Canna, SW, et al.
Publicado: (2015)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Shah, Mona, et al.
Publicado: (2013)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Redefining Dermatomyositis: A Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis From Overlap Myositis With Dermatomyositis Features
por: Troyanov, Yves, et al.
Publicado: (2014)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
por: de Jesus, A Almeida, et al.
Publicado: (2015)

Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype
por: Clarke, S. L. N., et al.
Publicado: (2020)

A de novo nonsense mutation in the tyrosine kinase lyn in a patient with an early onset autoinflammatory phenotype
por: De Jesus, Adriana Almeida, et al.
Publicado: (2014)

Type I interferon pathway in adult and juvenile dermatomyositis
por: Baechler, Emily C, et al.
Publicado: (2011)

Recurrent Inflammatory Panniculitis with Partial Lipoatrophy and Elevated temperature: a possible new autoinflammatory disorder
por: Torrelo, A, et al.
Publicado: (2015)

Case report: De novo SAMD9L truncation causes neonatal-onset autoinflammatory syndrome which was successfully treated with hematopoietic stem cell transplantation
por: Caldirola, María Soledad, et al.
Publicado: (2023)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0fr9p6b4rj3a16gl6pn8hd873